{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_11332", "batch_size": 200, "batch_pos": 95, "statement_text": "U.S. officials previously announced they were moving bulk vaccine from CSL Seqirus that closely matches the current virus into finished shots that could provide 4.8 million doses if needed.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment discusses vaccine doses factually, lacking high-potency framing.", "method": "llm_batch", "batch_id": "batch_2_17412", "batch_size": 200, "batch_pos": 62, "statement_text": "U.S. officials previously announced they were moving bulk vaccine from CSL Seqirus that closely matches the current virus into finished shots that could provide 4.8 million doses if needed.", "article_id": 1745}
